This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (28)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Kaija Seppä, MD; Pekka Sillanaukee, MSc; Timo Pitkäjärvi, MD; Matti Nikkilä, MD; Timo Koivula, MD

Arch Intern Med. 1992;152(2):297-300.

Abstract
Moderate alcohol consumption has been reported to provide protection against coronary heart disease. We studied serum lipid values in 380 men, including 184 controls (37 teetotalers and 147 moderate drinkers), 90 heavy drinkers, and 106 alcoholics. Total cholesterol values were significantly lower among alcoholics than controls (mean±SEM, 5.43±0.15 mmol/L [210±5.8 mg/dL] vs 6.01±0.08 mmol/L [232±3.1 mg/dL]), but their high-density lipoprotein (HDL) cholesterol values were higher (1.66±0.07 mmol/L [64±2.7 mg/dL] vs 1.14±0.02 mmol/L [44±0.8 mg/dL]). Accordingly, there was a highly significant difference in the HDL/total cholesterol ratio (0.32±0.13 vs 0.19±0.01). Heavy drinkers had significantly higher total cholesterol values than controls (6.30±0.13 mmol/L [244±5.0 mg/dL] vs 6.01±0.08 mmol/L [232±3.1 mg/dL]); the same was true of HDL cholesterol values (1.25±0.07 mmol/L [48±2.7 mg/dL] vs 1.14±0.02 mmol/L [44±0.8 mg/dL]). No significant difference was found in the HDL/total cholesterol ratio between controls and heavy drinkers or between teetotalers and moderate drinkers. Therefore, moderate alcohol intake apparently does not change HDL/total cholesterol ratio; if moderate drinking is protective against coronary heart disease, the mechanism is probably not via lipids.

(Arch Intern Med. 1992;152:297-300)

Author Affiliations
From the Departments of Public Health (Dr Seppä) and Clinical Sciences (Dr Nikkilä), University of Tampere (Finland); Department of Clinical Chemistry, Tampere University Central Hospital (Drs Sillanaukee and Koivula); and Community Health Center, City of Tampere (Dr Pitkäjärvi).

Footnotes
Accepted for publication July 31, 1991.

Reprint requests to Department of Public Health, University of Tampere, Box 607, SF-33101 Tampere, Finland (Dr Seppä).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Patient-Directed, Nonprescription Approaches to Cardiovascular Disease
Simon
Arch Intern Med 1994;154:2283-2296.
ABSTRACT  

Assessing possible hazards of reducing serum cholesterol
Law et al.
BMJ 1994;308:373-379.
ABSTRACT | FULL TEXT  

A Votre Sante
Kreisberg
Arch Intern Med 1992;152:263-265.
ABSTRACT